Drebrin Antibodies

Santa Cruz Biotechnology features a diverse variety of Drebrin monoclonal antibodies for investigating Drebrin's role in cellular processes. Drebrin monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Drebrin is a crucial actin-binding protein that plays a significant role in the regulation of dendritic spine morphology and synaptic plasticity. Drebrin maintains the structural integrity of neurons and influences various neurological processes. Research has shown that Drebrin expression levels are altered in several neurodegenerative conditions, making it an important target for neurological studies. Understanding Drebrin's function provides valuable insights into neurodevelopmental and neurodegenerative disorders. Investigating Drebrin's interactions with other proteins helps reveal its role in synaptic transmission and plasticity. Current research focuses on how Drebrin regulation affects neuronal development and function. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance our understanding of Drebrin's role in neurological health and disease.